ArticleCardiovascular ultrasound2026
Assessing the left atrial function via echocardiography to detect cirrhotic cardiomyopathy in patients with liver cirrhosis - a scoping review.
Article in Cardiovascular ultrasound, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCirrhotic cardiomyopathy (CCM) is a condition observed in patients with chronic liver disease, characterized by dysfunction in both cardiac diastolic and/or systolic function. This condition is often underdiagnosed due to a lack of awareness and the possibility of misdiagnosis. Consequently, there is limited data regarding subclinical CCM in individuals with end-stage liver disease. Furthermore, there is currently no established cardiac biomarker to assess cardiovascular risk and outcomes in patients with liver cirrhosis. To address this issue, we conducted a scoping review to map the existing evidence and identify research gaps in echocardiographic assessment of left atrial (LA) function for detecting CCM in patients with liver cirrhosis.
methodsWe systematically searched the Scopus, PubMed, and Web of Science databases using Population, Concept, and Context framework. The population is adult patients with liver cirrhosis. The concept is to assess LA function via echocardiography. Context is to detect CCM.
resultsWe identified 364 articles, of which 24 were eligible for full-text review. Ultimately, 20 articles were included in the final analysis. Our dataset revealed various cardiovascular manifestations involving LA. Key findings related to CCM included LA enlargement and increased LA diameter and volume, which correlated with the Child-Turcotte-Pugh and Model for End-Stage Liver Disease scores. Additionally, we observed a reduction in LA strain. LA diameter, volume, and LA strain were associated with outcome prediction.
conclusionEvaluating LA function with advanced echocardiographic techniques offers a promising approach for early detection and prognostic assessment of CCM. To translate these findings into standardized clinical practice, bridging existing evidence gaps with well-designed studies is crucial.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.